Treatment Effectiveness
User reported effectiveness ratings Quetiapine for various conditions.
Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
---|---|---|---|---|---|---|
Depression | 0% | 33% | 0% | 67% | 0% | 3 |
Side Effects
User-reported side effects of Quetiapine
Side Effect | Percent of Reports Quetiapine |
---|---|
Irritability | 46% |
Constipation | 27% |
Dry Mouth | 55% |
Breast Enlargement in Males | 5% |
Decreased Sexual Desire or Ability | 54% |
Difficulty Speaking or Using Language | 28% |
Difficulty Thinking or Concentrating | 67% |
Discharge From the Breasts | 3% |
Dizziness | 60% |
Drowsiness | 89% |
Excessive Weight Gain | 40% |
Increased Appetite | 47% |
Loss of Coordination | 38% |
Missed Menstrual Periods | 3% |
Numbness, Burning, or Tingling in the Arms or Legs | 12% |
Pain in the Joints, Back, Neck, or Ears | 23% |
Stomach Pain or Swelling | 20% |
Stuffy Nose | 21% |
Unusual Dreams | 47% |
Weakness | 41% |
Headache | 30% |
Gas | 24% |
Indigestion | 24% |
Outcomes
Below is the degree of change seen after Quetiapine is higher than average.

Outcomes Label
Outcomes
of
Below is the change in the listed outcome after
is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)"
title="Click to put the results with the largest observed change at the top"
>
Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)"
title="Click to put the results with the most supporting data points at the top."
>
Sort by Confidence
Quetiapine Info
Property | Value |
---|---|
Variable Name | Quetiapine |
Aggregation Method | SUM |
Analysis Performed At | 2020-03-17 |
Duration of Action | 21 days |
Filling Value | 0 |
Minimum Allowed Value | 0 count |
Number of Aggregate Predictors | 0 |
Number of Aggregate Outcomes | 0 |
Number of Measurements | 0 |
Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
Public | true |
Onset Delay | 30 minutes |
Unit | Count |
User Variables | 0 |
Variable Category | Treatments |
Variable ID | 94993 |